Category: Industry News

Genprex is Defining a New Immunogene Therapy that Could Change the Course of Cancer

Genprex is raising the standard in cancer treatment by developing what it calls an “immunogene therapy,” which harnesses the power of immunotherapy’s immunomodulation through the delivery of a gene therapy.

Read More

Pfizer’s Half-Billion-Dollar Manufacturing Facility Demonstrates Commitment to Gene Therapy

The passion for gene therapy and the new era of cell and gene-based medicine has made its way to the mainstream for treatment of serious diseases.

Read More

Thermo Fisher and Brammer Bio Deal Illustrates Rapid Growth for Gene Therapy

The gene therapy market is experiencing tremendous excitement, and these acquisitions strengthen the position that gene therapy is now a significant and key treatment option for patients with serious diseases or cancer.

Read More

IASLC 2019: Bringing Together Collaboration, Science and Hope for the Future

The IASLC 2019 Targeted Therapies of Lung Cancer Meeting left attendees feeling energized about the incredible work being done to improve patient outcomes for those with lung cancer.

Read More

Gene Therapy Now Coming into the Mainstream as Treatment Option for Serious Diseases

Roche’s acquisition of Spark Therapeutics confirms that gene therapy has finally made its debut as a treatment option for serious diseases.

Read More